NCT04348708 Long-Term Follow Up Study of Subjects Previously Administered HMI 102 Status ENROLLING_BY_INVITATION Phase N/A
NCT04085666 Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of CDX-6114 in Patients With Phenylketonuria (PKU) Status COMPLETED Phase PHASE1
NCT03516487 Safety and Tolerability of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria Status COMPLETED Phase PHASE1/PHASE2
NCT03097250 MRI Spectroscopy and Neuropsychological Functioning in Phenylketonuria Status COMPLETED Phase N/A
NCT02468570 A Phase 3 Substudy to Evaluate Executive Function in Adults With PKU Who Are Participating in the Phase 3 Study, 165-302 Status COMPLETED Phase N/A
NCT02297347 The Brain and Neuropsychological Functioning in Adults With Sapropterin Dihydrochloride Treated Phenylketonuria Status COMPLETED Phase N/A
NCT02176603 Observational Study of Endothelial Dysfunction in Phenylketonuria Status COMPLETED Phase N/A
NCT01977820 Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria Status TERMINATED Phase PHASE2
NCT01965912 Kuvan®'s Effect on the Cognition of Children With Phenylketonuria Status COMPLETED Phase PHASE4
NCT01924026 Neurocognitive Outcomes in Mild Hyperphenylalaninemia (MHP)MHP Study Status COMPLETED Phase N/A
NCT01917344 The Brain, Neurological Features and Neuropsychological Functioning in Adults With Phenylketonuria: A Pilot Study Status COMPLETED Phase NA